본문 바로가기

Metabolic Acidosis Is an Independent Risk Factor of Renal Progression in Korean Chronic Kidney Disease Patients: The KNOW-CKD Study Results

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
FRONTIERS IN MEDICINE8 · 2021
피인용
Web of Science 15Scopus 16
FWCI (Scopus)
1.29
JCR IF
JCR 2020 5.093
ISSN
2296-858X

저자

  1. 김효진제1저자Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea
  2. Ryu, HyunjinSeoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
  3. Kang, EunjeongEwha Womans Univ, Seoul Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
  4. Kang, MinjungSeoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
  5. 한미연Hallym Univ, Dept Internal Med, Hangang Sacred Heart Hosp, Seoul, South Korea
  6. 송상헌Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea
  7. Lee, JoongyubSeoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea
  8. Jung, Ji YongGachon Univ, Coll Med, Dept Internal Med, Gil Med Ctr, Incheon, South Korea
  9. Lee, Kyu-BeckSungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul, South Korea
  10. Sung, SuahEulji Univ, Eulji Med Ctr, Dept Internal Med, Seoul, South Korea
  11. 성은영Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea
  12. Ahn, CurieNatl Med Ctr, Dept Internal Med, Seoul, South Korea
  13. Oh, Kook-Hwan교신저자Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

초록

© Copyright © 2021 Kim, Ryu, Kang, Kang, Han, Song, Lee, Jung, Lee, Sung, Seong, Ahn and Oh.Background: We aimed to evaluate serum bicarbonate as a risk factor for renal progression, cardiovascular events, and mortality in Korean CKD patients. Methods: We analyzed 1,808 participants from a Korean CKD cohort whose serum bicarbonate levels were measured at enrollment. Serum bicarbonate levels were categorized as low, lower normal, higher normal, and high (total carbon dioxide <22, 22–26, 26.1–29.9, and ≥30 mmol/L, respectively) groups. Metabolic acidosis was defined as a serum bicarbonate level <22 mmol/L. The primary outcome was renal events defined as doubling of serum creatinine, 50% reduction of eGFR from the baseline values, or development of end-stage kidney disease. The secondary outcome consisted of cardiovascular events and death. In addition, patients whose eGFR values were measured more than three times during the follow-up period were analyzed for eGFR decline. The rapid decline in eGFR was defined as lower than the median value of the eGFR slope. Results: The mean serum bicarbonate level was 25.7 ± 3.7 mmol/L and 240 (13.2%) patients had metabolic acidosis. During the follow-up period of 55.2 ± 24.1 months, 545 (30.9%) patients developed renal events and 187 (10.6%) patients developed a composite of cardiovascular events and death. After adjustment, the low serum bicarbonate group experienced 1.27 times more renal events than the lower normal bicarbonate group [hazard ratio (HR): 1.27; 95% CI: 1.01–1.60, P = 0.043]. There was no significant association between the bicarbonate groups and the composite outcome of cardiovascular events and death. The low bicarbonate group showed a significantly rapid decline in eGFR [odds ratio (OR): 2.12; 95% CI: 1.39–3.22, P < 0.001] compared to the lower normal bicarbonate group. Conclusions: Metabolic acidosis was significantly associated with increased renal events and a rapid decline in renal function in Korean predialysis CKD patients.

키워드

chronic kidney diseasemetabolic acidosisrenal function declinerenal progressionserum bicarbonateSERUM BICARBONATE LEVELSFUNCTION DECLINEBASE-BALANCEOUTCOMESASSOCIATIONINFLAMMATIONPREVALENCEMORTALITY

식별자

Scopus EID
2-s2.0-85112420801
WoS UID
000684669900001